UPLOAD Filing
Erasca, Inc.
Date: Aug. 18, 2025 · CIK: 0001761918 · Accession: 0000000000-25-008699
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-289537
Letter
Re: Erasca, Inc. Registration Statement on Form S-3 Filed August 12, 2025 File No. 333-289537 Dear Dr. Jonathan E. Lim:
August 18, 2025
Dr. Jonathan E. Lim Chairman, Chief Executive Officer and Co-Founder Erasca, Inc. 3115 Merryfield Row, Suite 300 San Diego, CA 92121
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Daniel Crawford at 202-551-7767 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Matthew T. Bush, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> August 18, 2025 Dr. Jonathan E. Lim Chairman, Chief Executive Officer and Co-Founder Erasca, Inc. 3115 Merryfield Row, Suite 300 San Diego, CA 92121 Re: Erasca, Inc. Registration Statement on Form S-3 Filed August 12, 2025 File No. 333-289537 Dear Dr. Jonathan E. Lim: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Matthew T. Bush, Esq. </TEXT> </DOCUMENT>